136 related articles for article (PubMed ID: 35583911)
1. Inflammasome-related Markers upon ICU Admission do not Correlate with Outcome in Critically Ill COVID-19 Patients.
Adamik B; Ambrożek-Latecka M; Dragan B; Jeznach A; Śmiechowicz J; Gożdzik W; Skirecki T
Shock; 2022 May; 57(5):672-679. PubMed ID: 35583911
[TBL] [Abstract][Full Text] [Related]
2. High Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients.
Sivakorn C; Dechsanga J; Jamjumrus L; Boonnak K; Schultz MJ; Dondorp AM; Phumratanaprapin W; Ratanarat R; Naorungroj T; Wattanawinitchai P; Siripoon T; Duangdee C; Techarang T
Am J Trop Med Hyg; 2021 May; 105(1):73-80. PubMed ID: 33939645
[TBL] [Abstract][Full Text] [Related]
3. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
[TBL] [Abstract][Full Text] [Related]
4. Retrospective Cohort Observational Study to compare the Effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID-19 Patients.
Dixit S; Zirpe K; Suryawanshi P; Borawake K; Prasad S; Ambapkar S; Ambapkar S; Joshi A; Joshi M
J Assoc Physicians India; 2022 Jul; 70(7):11-12. PubMed ID: 35833395
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Badreldin HA; Alsalloum MA; Eljaaly K; Alharbi A; Aljehani R; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Al Aamer K; Al Enazi H; Almusallam M; Alshehri A; Bukhari R; Alasmari G; AlQahtani MM; Al Shammari S; Alsulaymi HO; Al Sulaiman K
J Intensive Care Med; 2023 Jun; 38(6):534-543. PubMed ID: 36683420
[No Abstract] [Full Text] [Related]
6. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study.
Sancho Ferrando E; Hanslin K; Hultström M; Larsson A; Frithiof R; Lipcsey M;
Cytokine; 2022 Jan; 149():155727. PubMed ID: 34628127
[TBL] [Abstract][Full Text] [Related]
7. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
Bülow Anderberg S; Luther T; Berglund M; Larsson R; Rubertsson S; Lipcsey M; Larsson A; Frithiof R; Hultström M
Cytokine; 2021 Feb; 138():155389. PubMed ID: 33348065
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment.
Bertoni A; Penco F; Mollica H; Bocca P; Prigione I; Corcione A; Cangelosi D; Schena F; Del Zotto G; Amaro A; Paladino N; Pontali E; Feasi M; Signa S; Bustaffa M; Caorsi R; Palmeri S; Contini P; De Palma R; Pfeffer U; Uva P; Rubartelli A; Gattorno M; Volpi S
J Allergy Clin Immunol; 2022 Oct; 150(4):796-805. PubMed ID: 35835255
[TBL] [Abstract][Full Text] [Related]
10. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
[TBL] [Abstract][Full Text] [Related]
11. Changes of plasma acetylcholine and inflammatory markers in critically ill patients during early enteral nutrition: A prospective observational study.
Tao G; Min-Hua C; Feng-Chan X; Yan C; Ting S; Wei-Qin L; Wen-Kui Y
J Crit Care; 2019 Aug; 52():219-226. PubMed ID: 31108325
[TBL] [Abstract][Full Text] [Related]
12. Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.
Gorham J; Moreau A; Corazza F; Peluso L; Ponthieux F; Talamonti M; Izzi A; Nagant C; Ndieugnou Djangang N; Garufi A; Creteur J; Taccone FS
PLoS One; 2020; 15(12):e0244628. PubMed ID: 33382773
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of serial evaluation of the Sequential Organ Failure Assessment (SOFA) score for intensive care unit mortality in critically ill patients with COVID-19: a retrospective cohort study.
Gruyters I; De Ridder T; Bruckers L; Geebelen L; Gharmaoui S; Callebaut I; Vandenbrande J; Berends N; Dubois J; Stessel B
Anaesthesiol Intensive Ther; 2022; 54(1):3-11. PubMed ID: 35266376
[TBL] [Abstract][Full Text] [Related]
15. Inflammasome signaling proteins as biomarkers of COVID-19.
Hadad R; Keane RW; de Rivero Vaccari JP
Front Immunol; 2023; 14():1014665. PubMed ID: 37168848
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory predictors at ICU admission affecting course of illness and mortality rates in a tertiary COVID-19 center.
Kukoč A; Mihelčić A; Miko I; Romić A; Pražetina M; Tipura D; Drmić Ž; Čučković M; Ćurčić M; Blagaj V; Lasić H; Dolenc E; Hleb S; Almahariq H; Peršec J; Šribar A
Heart Lung; 2022; 53():1-10. PubMed ID: 35104727
[TBL] [Abstract][Full Text] [Related]
17. The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.
Meertens JH; Nienhuis HL; Lefrandt JD; Schalkwijk CG; Nyyssönen K; Ligtenberg JJ; Smit AJ; Zijlstra JG; Mulder DJ
PLoS One; 2016; 11(8):e0160893. PubMed ID: 27529340
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy.
Campi I; Gennari L; Merlotti D; Mingiano C; Frosali A; Giovanelli L; Torlasco C; Pengo MF; Heilbron F; Soranna D; Zambon A; Di Stefano M; Aresta C; Bonomi M; Cangiano B; Favero V; Fatti L; Perego GB; Chiodini I; Parati G; Persani L
BMC Infect Dis; 2021 Jun; 21(1):566. PubMed ID: 34126960
[TBL] [Abstract][Full Text] [Related]
19. Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia.
Ruiz-Rodríguez JC; Chiscano-Camón L; Ruiz-Sanmartin A; Palmada C; Paola Plata-Menchaca E; Franco-Jarava C; Pérez-Carrasco M; Hernández-González M; Ferrer R
Front Med (Lausanne); 2021; 8():779038. PubMed ID: 35083241
[No Abstract] [Full Text] [Related]
20. The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis.
Volfovitch Y; Tsur AM; Gurevitch M; Novick D; Rabinowitz R; Mandel M; Achiron A; Rubinstein M; Shoenfeld Y; Amital H
Immunol Res; 2022 Dec; 70(6):817-828. PubMed ID: 36222965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
